Compare Roblox Corp (RBLX) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roblox Corp vs ResMed Inc. — how do they compare? Roblox Corp trades at $44.7 (market cap $32.02B), while ResMed Inc. trades at $219.5 (market cap $31.89B). The key difference: Roblox Corp and ResMed Inc. are close in size by market cap, and ResMed Inc. pays a 1.19% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| RBLX | RMD | |
|---|---|---|
Market Cap | $32.02B | $31.89B |
Sector | Media | Health |
52-Week High | $141.56 | $283.28 |
52-Week Low | $35.54 | $182.82 |
Enterprise Value | $30.84B | $31.24B |
Dividend Yield | — | 1.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Roblox (RBLX) trades at $44.82, up 3.49% today, with a bullish technical signal and strong revenue growth to $4.89B in 2025, though net losses persist. Recent earnings beats and positive cash flow trends contrast with high valuation ratios and regulatory scrutiny. The stock is near its consensus price target of $45.71, with support at $43 and resistance at $46.
Outlook: Long-term growth potential via user engagement and creator economy is tempered by profitability challenges and child-safety regulations. Risks include sustained losses and competitive pressure, but analyst sentiment leans slightly bullish with 44.74% buy ratings. Investors should weigh revenue momentum against margin improvement needs.
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
